https://www.selleckchem.com/pr....oducts/elamipretide-
RCIP was interpreted and reported as relative risk (RR) with 95% confidence intervals (CI) adjusted for gender, age cancer diagnosis, education, comorbidity, and sick leave weeks. Across cancer diagnoses 69 (83.1%) and 215 (81.4%) returned to work in the intervention and control group, respectively. No statistical effect was seen (RR 1.08 (95% CI 0.98-1.19)). Repeating the analyses solely for participants with breast cancer ( = 29 showed a significant effect of the intervention (RR 1.12 (95% CI 1.01-1.23)). More than 80%
Like
Comment
Share
